EBIT: Income before interest and taxes.
Virpax Pharmaceuticals, Inc. (VRPX) had EBIT of $-3.39M for the most recently reported fiscal quarter, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
$-3.39M |
|
-- |
|
-- |
|
$3.39M |
|
$-3.39M |
|
$0.00M |
|
$-3.39M |
|
$-3.39M |
|
$-3.39M |
|
$-3.39M |
|
$-3.39M |
|
$-3.39M |
|
|
EBIT |
$-3.39M |
$-3.39M |
|
0.17M |
|
0.17M |
|
$52.25 |
|
$52.25 |
|
| Balance Sheet Financials | |
$1.56M |
|
-- |
|
-- |
|
$1.56M |
|
$2.47M |
|
-- |
|
-- |
|
$2.47M |
|
$-0.91M |
|
$-0.91M |
|
$-0.91M |
|
0.60M |
|
| Cash Flow Statement Financials | |
$-16.71M |
|
-- |
|
$9.08M |
|
$9.14M |
|
$1.51M |
|
$-7.63M |
|
$0.13M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.63 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-16.71M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
371.01% |
|
371.00% |
|
-217.93% |
|
371.00% |
|
$-1.53 |
|
$-98.21 |
|
$-98.21 |
|